-The Indian Express The NDA government took over from the UPA more than eight months ago but it appears to be deja vu for activists fighting against the constitutionality of Section 66A of the Information Technology Act, which empowers police to arrest people for social media posts. Following the previous government's line, the NDA regime has lent its support to the validity of Section 66A, saying the "danger was present and clear"...
More »SEARCH RESULT
Total Matching Records found : 3611
Is the demographic profile changing? -Mayank Mishra
-Business Standard Eight states and UTs have Muslim share of population in excess of national average of 13% The argument given by supporters of the ghar wapsi (homecoming) CAMPAign is that unless corrective measures are taken up urgently, there is a danger to the existing demographic profile of the country. Many leaders of the Sangh parivar this reporter spoke to say that the way the population of some religious groups is growing,...
More »Let Them Eat Schemes -Ruhi Kandhari
-Tehelka Why is India struggling to feed its girls and women, who are in desperate need of nutrition, asks Ruhi Kandhari One out of three women or adolescent girls who come through that door are anaemic," says Dr Savita Agarwal, who runs a charitable clinic at a slum in north Delhi, pointing at the door of her clinic. "They cannot afford to eat meat, eggs, fruits and vegetables that provide iron." Fifty percent...
More »Fillip to cheaper hepatitis C drug -GS Mudur
-The Telegraph New Delhi: India's patent regulating agency today rejected a US company's patent claim on a drug to treat hepatitis C, raising hopes that generic drug makers could now produce cheaper versions of the medicine. The Indian Patents Controller has denied a patent to sofosbuvir from Gilead, a US biopharmaceutical company that had last year pledged to make the oral drug available in India and 90 other developing countries at $900...
More »Meningitis: Indian vaccine will protect infants also -R Prasad
-The Hindu The vaccine, which is heat stable, is a great Indian success story A meningitis A vaccine (MenAfriVac) manufactured by Serum Institute of India, Pune was approved by WHO a few days ago for use in infants in sub-Saharan African populations. The vaccine will be introduced as part of the routine immunisation programme. "In the four years since its introduction in Africa, MenAfriVac has had an immediate and dramatic impact in breaking...
More »
